Sun Pharmaceutical Industries Ltd will acquire Mumbai-based Innovcare Lifesciences Private Ltd for about $28.7 million (around Rs 271.2 crore) in an all-cash deal, as India's largest drugmaker looks to strengthen its product portfolio.
In an exchange filing on Saturday, Sun Pharma said it has signed an agreement to acquire 100 per cent of the outstanding shares of Innovcare Lifesciences. The transaction is expected to be completed on or before July 31, 2026.